Target intelligence / Profile preview

Membrane cofactor protein (CD46) and Myelin oligodendrocyte glycoprotein (MOG) (CD46/MOG)

Target
CD46/MOG
Molecular classification
Receptor, Complement regulatory protein, Immunoglobulin superfamily, Cell adhesion molecule
01

Overview

Host cell receptors for measles and rubella vaccine viruses are cell-surface proteins that facilitate the attachment and entry of attenuated vaccine strains. For measles vaccine strains (Edmonston-derived), the primary receptor is Membrane cofactor protein (CD46), a complement regulatory protein expressed on all nucleated human cells (Dorig et al., 1993; Naniche et al., 1993). This distinguishes vaccine strains from wild-type measles virus, which primarily uses Signaling lymphocytic activation molecule family member 1 (SLAMF1/CD150) and Nectin-4 (Tatsuo et al., 2000; Muhlebach et al., 2011). For the rubella virus, Myelin oligodendrocyte glycoprotein (MOG) has been identified as the principal host cell receptor (Kono et al., 2020). These receptors are essential for the efficacy of live-attenuated vaccines, such as the MMR vaccine, by determining tissue tropism and the resulting immune response. However, the interaction with MOG is a subject of study regarding rare neurological safety concerns like MOG-antibody associated disease (MOGAD).

Other names
CD46Membrane cofactor proteinMOGMyelin oligodendrocyte glycoproteinSLAMF1CD150Nectin-4PVRL4Signaling lymphocytic activation molecule family member 1Poliovirus receptor-related 4
02

Mechanism of action

Viral attachment and entry into host cells via receptor-mediated endocytosis or membrane fusion; measles vaccine strains utilize CD46, SLAMF1, or Nectin-4, while rubella virus utilizes MOG.

03

Biological functions

Viral entryComplement regulationCell-cell adhesionImmune response
04

Disease associations

InfectionMeaslesRubellaMOG-antibody associated disease (MOGAD)
05

Safety considerations

Autoimmune reactions (e.g., MOGAD)Complement dysregulationVaccine-associated adverse events in immunocompromised individuals
06

Interacting drugs

Measles virus vaccine

3 more in the full profile.

07

Biomarkers

CD46 expression levelsMOG antibody titersSLAMF1 expression

Beyond the preview

Go deeper on Membrane cofactor protein (CD46) and Myelin oligodendrocyte glycoprotein (MOG) (CD46/MOG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane cofactor protein (CD46) and Myelin oligodendrocyte glycoprotein (MOG) (CD46/MOG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call